Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A conservation device for oxygen therapy in COPD.

T W Evans1, J C Waterhouse, A J Suggett

  • 1Academic Division of Medicine, University of Sheffield, UK.

The European Respiratory Journal
|December 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pilot monitoring strategy for post-partum disease in an Australian dairy herd.

New Zealand veterinary journal·2021
Same author

'Warning: allergic to penicillin': association between penicillin allergy status in 2.3 million NHS general practice electronic health records, antibiotic prescribing and health outcomes.

The Journal of antimicrobial chemotherapy·2019
Same author

A One Health investigation of Salmonella enterica serovar Wangata in north-eastern New South Wales, Australia, 2016-2017.

Epidemiology and infection·2019
Same author

Man in Weightlessness.

Journal of the Royal College of Physicians of London·2019
Same author

A national quality incentive scheme to reduce antibiotic overuse in hospitals: evaluation of perceptions and impact.

The Journal of antimicrobial chemotherapy·2018
Same author

Human resources estimates and funding for antibiotic stewardship teams are urgently needed: authors' response.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same journal

Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

The European respiratory journal·2026
Same journal

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same journal

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same journal

Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

The European respiratory journal·2026
Same journal

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

The European respiratory journal·2026
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
See all related articles

The Oxymizer device, used for hypoxemia in COPD patients, increased arterial oxygen levels compared to standard nasal cannulae. However, its effectiveness in raising oxygen levels may decrease over time.

Area of Science:

  • Pulmonary Medicine
  • Respiratory Care
  • Biomedical Engineering

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) often leads to hypoxemia, necessitating oxygen therapy.
  • Domiciliary oxygen therapy is crucial for managing COPD patients' quality of life.
  • Novel delivery devices aim to improve oxygenation efficiency in patients with respiratory conditions.

Purpose of the Study:

  • To evaluate the impact of the Oxymizer nasal cannula on arterial blood gas tensions in COPD patients.
  • To compare the efficacy of the Oxymizer device against standard nasal cannulae in patients with severe hypoxemia and hypercapnia.
  • To assess the sustained effect of the Oxymizer device on oxygen and carbon dioxide levels over a 60-minute period.

Main Methods:

  • A crossover study design was employed involving twelve patients with severe hypoxemia and hypercapnia.

Related Experiment Videos

  • Baseline arterial blood gases (PaO2, PaCO2) were measured.
  • Oxygen was administered sequentially via standard nasal cannulae and the Oxymizer device, with measurements taken at 15-minute intervals.

    • Main Results:

    • The Oxymizer significantly increased mean PaO2 by 1.1 kPa compared to baseline (p < 0.001).
    • PaO2 levels were higher after 15 minutes of Oxymizer use than after 60 minutes (p < 0.05), suggesting a potential decline in efficacy.
    • No significant changes in PaCO2 were observed with either device (p > 0.05).

    Conclusions:

    • The Oxymizer nasal cannula effectively improves arterial oxygen tension in COPD patients with hypoxemia.
    • The short-term increase in PaO2 achieved with the Oxymizer may not be sustained over a 60-minute period.
    • Further research is warranted to explore the long-term efficacy and optimal use of reservoir nasal cannulae in COPD management.